PCVX

VAXCYTE INC

PCVX·92243G108·US·Common Stock·Healthcare - Biotechnology-13D/G

PCVX (VAXCYTE INC) is held by 164 institutional investors as of Q2 2026. Largest holders: FMR LLC ($1.2B), BlackRock, Inc. ($701.5M), RA CAPITAL MANAGEMENT, L.P. ($667M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 89 funds bought PCVX.

164
Holders
(14 Elite)
$6.3B
Total Value
54% (165)
Consensus
89 buying - 76 selling
13F: Insider & Congress: Updated regularly
PCVX

Smart Money Verdict

View all
Loading verdict
Held by 164 funds
14 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 5, 2026 · Activists Aug 11, 2026 · Congress Jun 8, 2026

ActivistJANUS HENDERSON GROUP Ltd.JANUS HENDERSON GROUP Ltd.12.1%Aug 11, 2026
ActivistJANUS HENDERSON GROUP Ltd.JANUS HENDERSON GROUP Ltd.0.1%Aug 7, 2026
InsiderDSDhaliwal Harpreet S.Sell $935KAug 5, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
20.9M(+26.4%)$1.2B0.1%-14.00%
39
Increased
12.1M(+10.0%)$701.5M0.0%-21.04%
35
Unchanged
11.5M$667M5.8%+22.74%
0
Increased
7M(+24.7%)$407M0.1%+11.18%
38
Increased
6.6M(+5.0%)$383.3M0.0%+2.26%
33
Increased
6.3M(+1.3%)$369M0.0%+2.16%
31
Increased
5.4M(+20.5%)$311.1M0.0%-2.43%
37
Increased
3.5M(+8.1%)$201.1M0.0%+11.98%
33
Decreased
2.5M(-32.2%)$143.7M0.5%+15.70%
0
Decreased
1.9M(-33.6%)$110.6M0.1%+43.87%
0
Increased
1.6M(+17.1%)$93.8M0.8%-18.31%
49
Increased
1.5M(+4.3%)$85.1M0.0%-6.88%
31
Increased
1.4M(+5.9%)$78.5M0.0%-16.56%
32
Increased
1.3M(+11.9%)$74.4M0.0%+12.43%
33
Increased
1.2M(+21.7%)$71.2M0.0%+14.41%
36
Increased
1.2M(+217.9%)$69.4M0.0%+6.45%
48
Decreased
1.2M(-16.8%)$68.9M0.2%-0.09%
0
Decreased
1.1M(-11.3%)$62.7M0.0%-1.01%
0
Increased
930,642(+10.5%)$54.1M0.0%+2.40%
32
Increased
880,000(+151.4%)$51.2M0.1%+16.93%
47

Showing 1-20 of 174

1 / 9
PCVXPCVXVAXCYTE INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used